Greenvale Capital’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,000,000
Closed -$34.7M 21
2022
Q4
$34.7M Sell
1,000,000
-1,216,755
-55% -$42.5M 3.09% 14
2022
Q3
$61.5M Sell
2,216,755
-283,245
-11% -$9.19M 6.32% 10
2022
Q2
$74.1M Buy
2,500,000
+1,850,000
+285% +$62.2M 8.08% 4
2022
Q1
$26.5M Buy
+650,000
New +$27.9M 2.99% 12
2021
Q2
Sell
-400,000
Closed -$17.7M 13
2021
Q1
$17.7M Sell
400,000
-800,000
-67% -$30.2M 1.92% 14
2020
Q4
$41.7M Buy
+1,200,000
New +$33.8M 4% 14

Other funds holding ADNT

Greenvale Capital's ADNT Position: Q1 2023 in Review

Greenvale Capital sold out of Adient (ADNT) in Q1 2023, closing a stake of 1,000,000 shares — an estimated $34.7M sold.

Greenvale Capital first reported a position in ADNT in Q4 2020 and held it in 6 quarters. The position peaked at $74.1M in Q2 2022. 275 funds tracked by Wall St. Rank hold ADNT as of Q1 2023.

  • Greenvale Capital reported no remaining Adient position as of Q1 2023 after selling out during the quarter.
  • Greenvale Capital sold 1,000,000 Adient shares in Q1 2023, an estimated $34.7M.
  • Greenvale Capital first reported a position in Adient in Q4 2020 and held it in 6 quarters.
  • Greenvale Capital's Adient position peaked at $74.1M in Q2 2022.
  • 275 funds tracked by Wall St. Rank held Adient as of Q1 2023.

Based on Greenvale Capital's 13F filing for Q1 2023, filed 15 May 2023.